Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
D000328:Adult; D001741:Black or African American; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects*; D008145:Louisiana; D008297:Male; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use; D012737:Sex Factors; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D044465:White People
D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D011736:Pyridoxine; D001663:Bilirubin; D007538:Isoniazid